Reaktion #8376

ord-4764fcefb6504a36872261252b2115e7

Reaktionsgleichung

Oc1[nH]nc(-c2ccccn2)c1-c1ccnc2ccccc12
5-pyridin-2-yl-4-quinolin-4-yl 2H-pyrazol-3-ol
OCCO
ethylene glycol
CCCCP(CCCC)CCCC
tri-n-butylphosphine
O=C(N=NC(=O)N1CCCCC1)N1CCCCC1
1,1′-(azodicarbonyl)dipiperidine
c1ccc(-c2nn3c(c2-c2ccnc4ccccc24)OCC3)nc1
title compound
Ausbeute 74.9%
c1ccc(-c2nn3c(c2-c2ccnc4ccccc24)OCC3)nc1
4-(6-Pyridin-2-yl-2,3-dihydro-pyrazolo[5,1-b]oxazol-7-yl)-quinoline
Ausbeute 74.9%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturThe solution is heated
  2. 2
    Temperaturat reflux for 5 h
  3. 3
    Temperaturcooled
  4. 4
    Filtrationfiltered through an SCX cartridge
  5. 5
    SonstigeThe residue is chromatographed on SiO2 (15:1 dichloromethane:methanol)

Vorschrift

To a solution of 5-pyridin-2-yl-4-quinolin-4-yl 2H-pyrazol-3-ol (50 mg, 0.17 mmol), ethylene glycol (15 mg, 0.24 mmol) and tri-n-butylphosphine (100 mg, 0.50 mmol) in tetrahydrofuran (15 mL) is added 1,1′-(azodicarbonyl)dipiperidine (120 mg, 0.48 mmol). The solution is heated at reflux for 5 h, cooled, and filtered through an SCX cartridge. The residue is chromatographed on SiO2 (15:1 dichloromethane:methanol). The product residue is converted to the disoxylate salt to give the title compound 40 mg (46%).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07087626B2uspto-grants-2006_08